Kensington Pharma

Kensington Pharma is a UK private pharmaceutical company focused on the innovation, identification, development, and commercialization of niche generic medicines for secondary care and hospital use. The company appears to specialize in generic injectable products and emphasizes affordable, dependable supply for the NHS and other hospital markets. Its marketed portfolio includes hospital medicines such as bivalirudin, chloramphenicol, ganciclovir, eptifibatide, and levetiracetam. Kensington Pharma also states that it is investing in improved drug-delivery approaches and patient-centric product strategies, working with associates and partners across development, manufacturing, regulation, and distribution. Overall, it looks like a small specialty generics company rather than a discovery-stage biotech.